|
1
|
Shrestha S, Tapper EE, Trogstad-Isaacson CS, Hobday TJ, Offer SM, Diasio RB. Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil. JCO Precis Oncol 2018; 2. [PMID: 32039342 DOI: 10.1200/po.18.00179] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- Shikshya Shrestha
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA
| | - Erin E Tapper
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA
| | | | - Timothy J Hobday
- Mayo Clinic College of Medicine, Rochester, MN 55905 USA.,Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905 USA
| | - Steven M Offer
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.,Mayo Clinic College of Medicine, Rochester, MN 55905 USA.,Mayo Clinic Cancer Center, Rochester, MN 55905 USA
| | - Robert B Diasio
- Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905 USA.,Mayo Clinic College of Medicine, Rochester, MN 55905 USA.,Mayo Clinic Cancer Center, Rochester, MN 55905 USA
| |
Collapse
|